Related Experiment Video
Updated: Oct 1, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Novel mutation of EPM2A causes progressive myoclonic epilepsy: a case report
Tao Liang1, Jing Wu2, Hongxing Chen1
1Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Abstract:
We report a case of progressive myoclonic epilepsy caused by a novel mutation in EPM2A. The female patient experienced abnormal jerky movements of the involving all four limbs and several generalized seizures, degeneration of cognition, and unsteadiness. Genetic analysis identified two rare, deleterious mutations in exon4: chr6: 145,948,751(c.G797G > A) and chr6: 145,948,761(c.T787C > T). The mutations at these two loci were from the genomes of their mother and father, respectively, which were compound heterozygous variations. This report updates the mutation sites of gene EPM2A and extends genotype-phenotype correlations in Lafora disease.

